Compounds > memantine
Page last updated: 2024-10-30

memantine and Chronic Primary Open Angle Glaucoma

memantine has been researched along with Chronic Primary Open Angle Glaucoma in 8 studies

Research Excerpts

ExcerptRelevanceReference
"POAG patients appear to have a genetic predisposition rendering them susceptible to ROS-induced damage because of a more frequent deletion, as compared to controls, of the gene encoding for glutathione-S-transferase M1, a pivotal anti-oxidant activity."2.43[Open angle glaucoma: epidemiology, pathogenesis and prevention]. ( De Flora, S; Di Marco, B; Izzotti, A; Saccà, S, 2006)
"The most common form of glaucoma, primary open angle glaucoma, is characterized by a chronically elevated intraocular pressure in the absence of any demonstrable structural abnormalities in the eye."2.40Excitatory mechanisms in retinal ganglion cell death in primary open angle glaucoma (POAG). ( Dreyer, EB; Grosskreutz, CL, 1997)

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (12.50)18.2507
2000's6 (75.00)29.6817
2010's1 (12.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Weinreb, RN1
Liebmann, JM1
Cioffi, GA1
Goldberg, I1
Brandt, JD1
Johnson, CA1
Zangwill, LM1
Schneider, S1
Badger, H1
Bejanian, M1
Danesh-Meyer, HV1
Levin, LA1
Sawaguchi, S1
Greenfield, DS1
Girkin, C1
Kwon, YH1
Izzotti, A1
Di Marco, B1
De Flora, S1
Saccà, S1
Dreyer, EB1
Grosskreutz, CL1
Grehn, F1
Pop, E1

Reviews

4 reviews available for memantine and Chronic Primary Open Angle Glaucoma

ArticleYear
Neuroprotection: extrapolating from neurologic diseases to the eye.
    American journal of ophthalmology, 2009, Volume: 148, Issue:2

    Topics: Animals; Clinical Trials as Topic; Disease Models, Animal; Endpoint Determination; Excitatory Amino

2009
[New informations on medical treatment for normal-tension glaucoma].
    Nippon Ganka Gakkai zasshi, 2004, Volume: 108, Issue:7

    Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Calcium Channel Blockers; Filtering Surgery; G

2004
[Open angle glaucoma: epidemiology, pathogenesis and prevention].
    Recenti progressi in medicina, 2006, Volume: 97, Issue:1

    Topics: Adrenergic beta-Antagonists; Age Factors; Aged; Aqueous Humor; Calcium Channel Blockers; DNA Damage;

2006
Excitatory mechanisms in retinal ganglion cell death in primary open angle glaucoma (POAG).
    Clinical neuroscience (New York, N.Y.), 1997, Volume: 4, Issue:5

    Topics: Animals; Cell Death; Excitatory Amino Acid Antagonists; Glaucoma, Open-Angle; Glutamic Acid; Humans;

1997

Trials

1 trial available for memantine and Chronic Primary Open Angle Glaucoma

ArticleYear
Oral Memantine for the Treatment of Glaucoma: Design and Results of 2 Randomized, Placebo-Controlled, Phase 3 Studies.
    Ophthalmology, 2018, Volume: 125, Issue:12

    Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Disease Progression; Double-Blind

2018

Other Studies

3 other studies available for memantine and Chronic Primary Open Angle Glaucoma

ArticleYear
Memantine and progressive glaucoma.
    Journal of glaucoma, 2005, Volume: 14, Issue:1

    Topics: Aged; Complementary Therapies; Disease Progression; Excitatory Amino Acid Antagonists; Female; Filte

2005
[Prospects for neuroprotective glaucoma therapy].
    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2001, Volume: 98, Issue:10

    Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Apoptosis;

2001
Trends in neuroprotection.
    Archivos de la Sociedad Espanola de Oftalmologia, 2002, Volume: 77, Issue:6

    Topics: Aged; Amlodipine; Animals; Antiparkinson Agents; Apoptosis; Brain Diseases; Calcium Channel Blockers

2002